Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EG Bio Co., Ltd. is a South Korean biotechnology company specializing in the development and manufacture of molecular diagnostic (MDx) solutions. Founded in 2010, the company provides a comprehensive portfolio of PCR-based kits and reagents designed for the high-sensitivity detection of infectious diseases and oncology markers. Their flagship products include diagnostic tools for COVID-19, human papillomavirus (HPV), and tuberculosis, which are utilized by clinical laboratories and hospitals worldwide. EG Bio focuses on advancing precision medicine through innovative diagnostic technologies that improve patient outcomes and public health monitoring. The company is headquartered in Anyang, South Korea, and maintains a strong presence in the global diagnostics market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EG Bio.